0001656472-21-000035.txt : 20210318 0001656472-21-000035.hdr.sgml : 20210318 20210318174934 ACCESSION NUMBER: 0001656472-21-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN CENTRAL INDEX KEY: 0001797199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 21755624 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wf-form4_161610415705055.xml FORM 4 X0306 4 2021-03-16 0 0001656472 Cronos Group Inc. CRON 0001797199 GORENSTEIN MICHAEL RYAN 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 1 1 0 0 Executive Chairman COMMON SHARES 2021-03-16 4 M 0 437500 1.9391 A 8870036 D COMMON SHARES 2021-03-16 4 F 0 175178 10.6974 D 8694858 D COMMON SHARES 2021-03-16 4 M 0 1272916 2.5161 A 9967774 D COMMON SHARES 2021-03-16 4 F 0 559960 10.6974 D 9407814 D COMMON SHARES 2021-03-16 4 M 0 103125 6.0658 A 9510939 D COMMON SHARES 2021-03-16 4 F 0 70427 10.6974 D 9440512 D COMMON SHARE OPTION (right to buy) 1.9391 2021-03-16 4 M 0 437500 0 D 2022-08-24 COMMON SHARES 437500.0 62500 D COMMON SHARE OPTION (right to buy) 2.5161 2021-03-16 4 M 0 1272916 0 D 2022-04-12 COMMON SHARES 1272916.0 27084 D COMMON SHARE OPTION (right to buy) 6.0658 2021-03-16 4 M 0 103125 0 D 2023-05-17 COMMON SHARES 103125.0 46875 D The price reported was converted from the Canadian exercise price of C$2.42 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021. Cronos Group Inc. (the "Company") withheld 175,178 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange. The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021. The price reported was converted from the Canadian exercise price of C$3.14 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021. The Company withheld 559,960 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange. The price reported was converted from the Canadian exercise price of C$7.57 to U.S. dollars using an exchange rate of C$1.00 to US$0.8013 as reported by Bloomberg as of March 15, 2021. The Company withheld 70,427 common shares underlying the options for payment of the exercise price and to cover applicable withholding taxes, using the closing price of the Company's common shares on March 15, 2021 of C$13.35 as reported on the Toronto Stock Exchange. The options were granted August 24, 2017 and vest in monthly installments over a four-year period. The options were granted April 12, 2017 and vest in monthly installments over a four-year period. The options were granted May 17, 2018 and vest in monthly installments over a four-year period. /s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein 2021-03-18